Abnormal atrial refractoriness was examined as a cause of atrial fibrillation/flutter (AFF) in patients with bradycardia. Refractory periods at three disparate right atrial sites were compared in 17 patients with sinus node dysfunction (SND) and 16 controls. Atrial pacing shortened refractory periods, but failed to decrease dispersion of refractoriness significantly. During sinus rhythm, duration and dispersion of refractoriness were greater in SND patients than in controls. These differences persisted with atrial pacing. For example, at the paced rate, dispersion of effective refractory periods in SND patients was greater than in controls (62.9 ± 34 vs 36.6 ± 21 msec,p < 0.01). Six SND patients had AFF, but they did not have greater dispersion than other SND patients, or unusually short or long refractory periods. Thus, prolonged and nonuniform refractoriness were features of SND. Abnormal refractoriness in SND reflected atrial disease and persisted with pacing. These abnormalities were not unique to patients with AFF.
EARLY ATRIAL EXTRASYSTOLES are critical to the initiation of atrial fibrillation and flutter (AFF).1, 2 According to one theory, AFF results from nonuniform recovery of excitability3 4 and nonhomogeheous spread of the early excitation. 5 Thus, AFF results when there is dispersion of atrial refractoriness. Because slower heart rates have been shown to increase the normal dispersion of canine atrial refractoriness,6 bradycardia should predispose to ectopic atrial rhythms.7 A clinical model of this theory would be the bradycardia-tachycardia sequences in some patients with sinus node dysfunction (SND).6 9 HIowever, faster heart rates curtail atrial refractoriness in man, exposing the vulnerable zone to excitation.'0 Thus, vulnerability to AFF from early extrasystoles could reflect a shortened refractory period rather than dispersion of refractory periods. Alternative explanations for atrial tachycardias include enhanced automaticity or tachycardias triggered from afterpotentials." These mechanisms suggest that faster, not slower heart rates, predispose to AFF.
In this investigation we assess atrial refractoriness in patients with SND to delineate the role of bradycardia in determining dispersion of refractoriness and arrhythmia in man. In this preliminary investigation, measurements were limited to the right atrium of patients without obvious hemodynamic abnormalities.
Materials and Methods

Patient Population
Atrial refractory periods were measured in 33 patients after they gave informed, written consent. All were studied in the postabsorptive state and had received no cardioactive medications for at least 5 half-lives. No patient had overt congestive heart failure at the time of study or was thought to have significant valvular heart disease.
Sixteen patients (table 1) , studied for ventricular ectopy or unexplained syncope, were considered as controls because they did not have supraventricular arrhythmias. Neither AFF nor sinus pauses were recorded during at least 24 hours of tape-recorded ambulatory (Holter Avionics) or computer-assisted bedside (Siemens Cardioalarm) monitoring. All had normal sinus node recovery times (range 910-1350 msec)'2, 13 and sinoatrial conduction times (range 73-127 msec). '4 Seventeen patients (table 2) were considered to have SND because of episodes of light headedness or syncope and persistent sinus bradycardia (< 60 beats/min) on three or more occasions, symptomatic sinus bradycardia (< 35 beats/min), sinus arrest longer than 2 seconds or prolonged sinus node recovery or sinoatrial conduction times. Six of these patients (table 2, patients [12] [13] [14] [15] [16] [17] had spontaneous paroxysms of sustained AFF. All were in sinus rhythm at the initiation of the study, except for patient 13, who was studied after overdrive pacing converted him from atrial flutter.
There was not a significant difference in age or sex distribution between control patients and patients with SND.
Patients were excluded from study if there was Wolff-Parkinson-White syndrome or reciprocating supraventricular tachycardia and if recorded arrhythmias were associated with possible drug toxicity or an episode of ischemia or congestive failure.
Stimulation and Recording Techniques
Atrial stimulation was performed using two poles of 404 DISPERSION OF ATRIAL REFRACTORINESS/Luck and Engel Abbreviations: AV = atrioventricular; IVCD = intraventricular conduction delay; LAD = left-axis deviation; LAFB = left anterior fascicular block; LVH = left ventricular hypertrophy; PA Fib = paroxysmal atrial fibrillation; PA Flut = paroxysmal atrial flutter; SACT = sinoatrial conduction time expressed as (A2A3-AiAi)/2; SB = sinus bradyeardia; SNRT = sinus node recovery time; VEBs = ventricular ectopic beats. 237  240  267  263  237  203  228  200  280  250  263  257   60  70  50  100  85  80  55  30  140  20  50   60  90  40  100  63   362  300  312  298  343  306  282  255  287  303  290  252  268  240  322  280  320  295   35  20  45   100  90  140  15  40  120  50  30  65  15  120  85  20  160  68  36  34   32  47 Abbreviations: ERP = effective refractory period; FRP = functional refractory period. a quadripolar catheter, or a bipolar catheter, with interelectrode distance of 1 cm, passed to the right atrium via basilic or femoral veins. Twice threshold stimuli were provided by a Grass S88 stimulator electrically isolated with SIU5 units or an electrically isolated battery-powered Medtronics 5325 stimulator. The stimulating poles were first positioned at the high right atrium near its junction with the superior vena cava for determination of sinus node recovery time and sinoatrial conduction time, using previously described techniques.12-4 Atrial extrastimuli were applied at 10-msec decrements after every eighth sinus beat or after eight beats of atrial pacing at a rate of 120 beats/min, until atrial refractoriness. The stimulating poles were then fluoroscopically repositioned, the threshold was redetermined, and atrial extrastimulation done at two right atrial sites at least 1 cm distant from the high right atrium (such as mid-lateral, low-lateral, or mid-septal right atrium). The positions chosen were those that resulted in stable pacing using looped catheter configurations with the pacing poles under tension. Constant atrial capture was assured when threshold and fluoroscopic position were fixed.
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Atrial electrograms were recorded from the other poles of the quadripolar catheter, or on occasion from a second bipolar catheter fluoroscopically positioned in the anteroposterior view 1 cm from the stimulating poles. Recordings were made at 100 mm/sec paper speed and filter settings of 30-500 Hz with an Electronics for Medicine DR-12 oscilloscope recorder. The first deflection in amplified recordings of the atrial electrogram was taken as the onset of atrial depolarization, so as to best reflect the timing of the onset of depolarization at the stimulating site. Surface leads I, II, aVF and V1 were recorded as well. The effect ofincreasing heart rate (by atrialpacing) on atrial effective andfunctional refractory periods. Patients with sinus node dysfunction are indicated by the solid lines and the controls by the interrupted lines. The average right atrial refractory period of the three sites is shown on the upper portion of the graph, and the dispersion of refractory periods on the lower portion. In every instance, average refractoriness and dispersion of refractoriness are different for sinus node dysfunction patients vs controls. Contrary to the text, standard errors rather than standard deviations are shown. There is a decrease in average refractory period and dispersion at the increased heart rate, but the latter change is not significant.
Analysis of Data
Atrial functional refractory period (FRP) was the shortest coupling interval recorded on the atrial electrogram. Effective refractory period (ERP) was the longest interval from the atrial electrogram (sinus rhythm) or stimulus artifact (atrial pacing) to the extrastimulus failing to propagate. Dispersion of atrial refractoriness was determined from the range of refractory periods measured in each patient (as the longest minus shortest refractory period).
Vulnerability to atrial extrastimulation was diagnosed when an extrastimulus was followed by longer than 1 second of disorganized atrial activity or more than three depolarizations with cycle length of < 250 msec (with fibrillation or flutter waves on the surface leads). '5 Heart rates and sinus node recovery time were related to dispersion of refractoriness using linear regression or Spearman rank correlation. Refractoriness at the two rates (sinus rhythm and 120 beats/min) was compared with a paired t test. Group comparisons were made with a one-tailed, unpaired t test, comparison of subgroups was made with analysis of one-way variance, and prevalence of vulnerability was compared using a chi-square test with Yates' correction. (table 3) During sinus rhythm (73.8 7.1 beats/min), the average ERP in control patients was 270 ± 24 msec (SD). At the atrial paced rate (120 beats/min) ERP shortened to 241 + 23 msec (p < 0.001) ( fig. 1) . Similarly, average FRP shortened from 310 ± 36 to 276 ± 34 msec (p < 0.001).
Results
Atrial Refractoriness in Control Patients
During sinus rhythm, the average dispersion of ERP was 42.8 ± 26 msec (range 15-125 msec). The average dispersion of FRP was 40.9 ± 27 msec (range 10-115 msec). Dispersion of refractoriness did not correlate with sinus cycle length (r = -0.29 and -0.16). With pacing, the average dispersion of ERP was 36.6 ± 21 (range 10-70 msec) and the average dispersion of FRP was 37.5 ± 24 msec (range 10-90 msec). Figure 2 illustrates the determination of dispersion of refractoriness in a representative control patient.
Despite reduction in average ERP with pacing, the reduction of dispersion of ERP was not significant ( fig. 1 ). Similar results were found for FRP. Also, there was no correlation between the absolute change in dispersion of ERP with atrial pacing and the extent PATIENT NUMBERS of cycle length abbreviation (r = -0.11) or the shortening of average ERP (r = -0.39).
Atrial Refractoriness in Patients with SND (table 3) During sinus rhythm (60.8 + 13.4 beats/min), the average ERP of SND patients was 322 74 msec, which was greater than control ERP (270 24 msec) (p < 0.01). With atrial pacing there was significant abbreviation of average ERP (p < 0.001) ( fig. 1 ). However, at the paced heart rate, the average ERP of SND patients was still longer than that of controls (257 ± 36 vs 241 ± 23 msec, p = 0.06).
Similarly, average FRP shortened from 378 + 71 to 295 ± 32 msec with atrial pacing (p < 0.001) ( fig.  1 ), but remained longer than the average paced FRP of controls (276 ± 34 msec, p < 0.05). Figure 3 demonstrates abnormal dispersion of refractoriness in a representative SND patient. During sinus rhythm, the average dispersion of ERP was 91.8 ± 86 msec. This was significantly greater than dispersion of ERP in controls (42.8 26 msec) (p < 0.02). But with atrial pacing, dispersion of ERP decreased only to 62.9 ± 34 msec (NS) ( fig. 1 ). Dispersion did not significantly narrow with pacing, despite unusually wide dispersion during sinus rhythm in several patients (for example, cases 3 and 16) that could have been due to sinus arrhythmia or a change in catheter positions. As was true for controls, there was no correlation between the change in dispersion of ERP with atrial pacing and the extent of cycle length abbreviation (r = 0.27) or the shortening of average ERP (r = 0.44).
Thus, with bradycardia discounted at the paced heart rate, and with a substantial shortening of average refractoriness (above), dispersion of ERP remained greater than that seen in controls (62.9 ± 34 vs 36.6 ± 21 msec,p < 0.01). Figure 4 illustrates that dispersion of ERP exceeding that seen in controls (greater than 70 msec) persisted in six SND patients, despite atrial pacing.
Similar results were found for dispersion of FRP, which during sinus rhythm was greater in SND patients (87.1 81 msec) than in controls (40.9 ± 27 msec, p < 0.05). Dispersion failed to decrease significantly with atrial pacing, and remained greater at the paced heart rate in SND patients (67.6 ± 47 msec) than in controls (37.5 24 msec, p < 0.02).
The magnitude of dispersion of ERP and FRP during sinus rhythm did not correlate with heart rate (r = -0.22 and -0.09). Similarly, the magnitude of dispersion of ERP and FRP at the paced heart rate did not consistently reflect the severity of the SND, as estimated by sinus node recovery time (r = 0.40 and 0.21) or by clinical status (there were patients with syncope from SND with minimal dispersion of refractoriness).
Dispersion of Atrial Refractoriness in Patients with AFF
Only three of six patients with clinically documented AFF had increased dispersion of ERP during sinus rhythm compared with controls (130, 150 and 200 msec), and only two of these had increased dispersion of ERP during pacing compared with controls (90 and 100 msec) ( fig. 4 ). Only two patients with AFF had increased dispersion of FRP (table 3) . Usually, increased dispersion was confined to patients who had only atrial fibrillation. Those who Abbreviations: AFF = atrial fibrillation and flutter; ERP = effective refractory period; FRP functional refractory period; SND = sinus node dysfunction; SR = sinus rhythm. also had recorded episodes of atrial flutter tended to have normal dispersion of ERP during pacing (5, 35 and 40 msec). Data were similar for FRP (table 3) .
However, there were four SND patients with increased dispersion of ERP during pacing compared with controls (80, 85, 100 and 140 msec) who had clinical documentation of neither atrial fibrillation nor flutter. Three had increased dispersion of FRP during pacing. Thus, the prevalence of abnormal dispersion of refractoriness was the same in SND patients with AFF (33% during pacing) and without clinically documented AFF (27-36% during pacing). Table 4 indicates the variance of atrial refractory periods between the subgroups of controls, SND without AFF, and those with AFF. In this study, increased dispersion of atrial refractoriness was associated with SND, but no more than with AFF. Table 4 indicates that the sites of longest refractoriness were discovered in SND patients who did not have AFF. Patients with AFF tended to have atrial sites with shorter refractory periods than other SND patients. This is illustrated in figure 4, although the differences from the overall population studied were not significant.
In summary, AFF was not associated with unique abnormalities of atrial refractoriness in the present investigation.
Patients Vulnerable to AFF from Atrial Extrastimulation
Eight patients were vulnerable to AFF from extrastimulation: three of 16 control patients, one of 11 SND patients with sinus bradycardia or arrest, and four of six SND patients with paroxysms of AFF. Thus, in the presence of SND, vulnerability was associated with clinical documentation of AFF (chisquare = 7.25, p < 0.01). Vulnerability was seen at the atrial site with the shortest ERP and FRP in all but one patient.
Comparisons were made from data during atrial pacing, when vulnerability was usually seen. In previous reports'0 15-17 vulnerability has been described in terms of FRP. The three vulnerable control patients had an average dispersion of FRP of only 28.3 msec. Dispersion of FRP was normal in two SND patients (15 and 65 msec) and increased in three (120, 120 and 160 msec). Vulnerable patients did not have very short FRP compared with the shortest FRP among the 13 control patients that were not vulnerable to AFF from extrastimulation (240 ± 34 versus 258 ± 33 msec, p = NS). Vulnerable patients did not have very long FRP compared with the longest FRP among the 12 SND patients that were not vulnerable (311 ± 52 vs 334 ± 41 msec, NS). Similar results were found for ERP.
In summary, as with clinical paroxysms of AFF, vulnerability to AFF was not associated with unique abnormalities of atrial refractoriness.
Discussion
Patients with SND are likely to have atrial disease as well. Atrial disease is suggested by the AFF that occurs in bradycardia-tachycardia syndrome, and by pathologic surveys. '8-22 The present investigation describes prolonged and nonuniform atrial refractoriness as additional features of SND. The abnormalities of atrial refractoriness that accompanied SND persisted when the role of bradycardia was discounted by atrial pacing. This indicates that prolonged and nonuniform refractoriness reflected intrinsic atrial disease.
The abnormalities of atrial refractoriness described in our patients with SND are more striking if one considers the techniques used. These might have served to lessen differences from controls, or the numbers of SND patients found to be abnormal. The data from control patients were similar to those reported from animal preparations. Han et al.6 found average dispersion to be 54 msec (canine atria, 500-msec cycle length), Alessi et al. 23 reported less than 40 msec (canine right atrium, 375-msec cycle length), Zipes et al. 24 reported 60 msec with a range of 25-110 msec (canine left and right atria, unspecified cycle length) and Allessie et al. 25 less than 30 msec (rabbit left atrium, 500-msec cycle length). However, compared with animal studies, our protocol had less precision because: 1) our measurements were limited to the right atrium; 2) constant atrial capture during endocardial stimulation cannot be assured using catheters positioned in the relatively smooth walled right atrium; 3) we measured refractory periods at only three sites. Han et al.,6 measured refractory periods at six sites. Measurement at additional sites would probably increase the yield of abnormal sites; 4) our comparison group was not entirely normal, having undergone electrophysiologic study for symptoms or ECG abnormalities, and was a control group only in the sense that they did not have SND or atrial arrhythmias. Greater differences between SND patients and normal volunteers might have been seen. Despite these limitations, some abnormality of duration or dispersion of ERP or FRP was seen in 12 of 16 patients with SND (table 3) .
Although bradycardia dramatically influenced the duration of refractory periods, we were unable to demonstrate that bradycardia significantly increased dispersion of atrial refractoriness. The minor role of heart rate as a determinant of dispersion of atrial refractoriness in man, compared with canines, might be explained by interspecies differences or the pentobarbital anesthesia given to dogs. The vagi were cut and the stellate ganglia excised in the dogs.6 Uniformity of refractoriness is in part determined by vagal tone,23, 24 and autonomic innervation could serve to maintain uniformity at different paced rates. The importance of autonomic innervation was illustrated in patients by Goodman et al.,26 who found differences in the response to atrial extrastimulation (vulnerability to arrhythmia) in denervated human hearts that were felt to be consistent with nonhomogeneous repolarization.
The range of heart rates studied could explain why cycle length did not significantly influence dispersion of refractoriness. Han et al. 6 crushed the sinus node of their dogs and measured dispersion at paced cycle lengths of 200-700 msec. The major changes in dispersion seen were at cycle lengths of 300-600 msec; there was little change between 200-300 msec and between 600-700 msec. The 500-1200 msec cycle length range has not been previously investigated.
Bradycardia was not the primary reason for increased dispersion of atrial refractoriness in patients with SND. Furthermore, bradycardia-enhanced dispersion of refractoriness did not explain paroxysms of AFF in our SND patients, because increased dispersion of refractoriness was not unique to or invariable in patients with AFF at any heart rate. In fact, three patients without SND had paroxysmal AFF with normal dispersion (unpublished data).
In addition, we failed to identify focal abnormalities of longer or shorter refractoriness unique to patients with AFF, either during sinus rhythm, or when bradycardia was discounted by atrial pacing. The "leading circle" hypothesis of Allessie and co-workers5 suggests that atrial tachyarrhythmia is more likely with large areas of longer refractoriness. But the sites of longest refractoriness were discovered in SND patients who did not have AFF (table 4) . Possibly, we failed to discover critical areas of prolonged refractoriness that were the "obstacles" for atrial circus movements because of limited numbers of measurements. Alternatively, many of our SND patients might have been capable of sustaining paroxysms of AFF that were not discovered by brief (24-72-hour) monitored periods or the extrastimulus technique. Prolonged monitoring or very rapid atrial pacing might have exposed AFF that correlated with abnormal refractory periods. Further data are necessary from patients who do not have SND to assess properly abnormalities of refractoriness in the genesis of AFF.
On the basis of extrastimulus studies, Wyndham et al.'0 have suggested that abbreviation of refractoriness might predispose to AFF by exposing the vulnerable zone. Using similar techniques, we have previously suggested that AFF is more likely when there are localized sites of abbreviated refractoriness.'5 In the present study, neither SND, clinically documented AFF, or vulnerability to AFF from extrastimulation were associated with localized sites of abbreviated refractoriness. Vulnerable patients did not consistently show increased dispersion of refractoriness or sites of prolonged refractoriness. These results are consistent with the absence of abnormalities unique to SND patients with spontaneous AFF. Just as vulnerability to AFF cannot be used to predict spontaneous paroxysms of AFF,27 abnormal refractoriness does not explain atrial vulnerability.
Clinical reports also suggest that reversal of bradycardia does not necessarily eliminate AFF. When Goel and Han reported that atropine eliminated atrial ectopy in the setting of sinus bradycardia, they merely referred to isolated ectopic beats.7 Patients treated with permanent ventricular pacemakers for bradycardia-tachycardia syndrome have not shown consistent relief from AFF by pacing alone,'8' 28, 29 and eventually, permanent atrial fibrillation supervenes even with pacing. 29' 30 Drugs are often required to control AFF even when atrial pacing is used.8' 31 In summary, prolonged and nonuniform atrial refractoriness was found in patients with SND; but these newly described abnormalities reflected atrial disease and not the slower heart rates seen with SND. Furthermore, prolonged or nonuniform refractoriness were not the critical determinants of AFF in SND. In keeping with recent reports on atrial vulnerability,'0 1' these data suggest that relief of bradycardia by pacing will not prevent AFF. 411 
